Abstract PTH-161 Table 1
GroupKnown IBD(%)New IBD(%)PUD(%)NSI(%)Cancer(%)CRA(%)Coeliac(%)Unknown(%)Other(%)
Age < 55 + FCP 60–100 (n = 15)AB4 (26.7)AB0 (0.0)AB0 (0.0)AB2 (13.3)AB0 (0.0)AB0 (0.0)AB0 (0.0)AB1 (6.7)AB8 (53.3)
Age < 55 + FCP > 100 (n = 68)AB39 (57.4)AB6 (8.8)AB2 (2.9)AB3 (4.4)AB0 (0.0)AB0 (0.0)AB1 (1.5)AB4 (5.9)AB13 (19.1)
Age > 55 + FCP 60–100 (n = 11)AB3 (27.3)AB0 (0.0)AB0 (0.0)AB0 (0.0)AB0 (0.0)AB1 (9.1)AB0 (0.0)AB0 (0.0)AB7 (63.6)
Age > 55 + FCP > 100 (n = 42)AB22 (52.3)AB2 (4.8)AB0 (0.0)AB0 (0.0)AB2 (4.8)AB2 (4.8)AB0 (0.0)AB2 (4.8)AB12 (28.5)